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Inflammatory skin is the most common dis­
order in dermatology. Psoriasis and atopic der­
matitis are the two main chronic conditions of 
inflammatory skin diseases and originate from 
an aberrant interaction between the skin and the 
immune system (Pittelkow, 2005). Character­
istics of inflamed scaly skin are hyperprolifera­
tion and altered differentiation of keratinocytes, 
as well as increased inflammatory cell infiltra­
tion and blood vessel formation (Lowes et al., 
2007; Wagner et al., 2010). Beyond environ­
mental factors, a large set of hereditary factors, 
including many genes related to the immune 
system, contribute to the onset of the disease 
(Nestle et al., 2009). Some alterations in genes 
related to proper skin barrier function like fil­
aggrin have also been implicated (Proksch et al., 
2008; Roberson and Bowcock, 2010). Deficien­
cies in physical, biochemical, or immunological 
compositions enable percutaneous penetration of 
chemicals and microbes, which promotes inflam­
mation. In mice, transgenic studies addressed the 
contribution of key signaling pathways to model 
psoriatic skin, including STAT3, AP­1, TGF­, 
NF­B, and VEGF pathways (Gudjonsson et al., 
2007; Swindell et al., 2011). These genetic 
studies have yielded insights into the regulation 
of complex inflammatory circuits, contributed to 
unraveling molecular and cellular changes that 
are consistently detected in psoriatic plaques, and 
contributed to developing novel therapeutic 
strategies (Wagner et al., 2010).
The contribution of Wnt signaling to the 
pathogenesis of chronic inflammatory skin dis­
eases has not been studied in great detail. A genetic 
link between pathological skin malformations 
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Cells of the epidermis renew constantly from germinal layer stem cells. Although epithelial cell 
differentiation has been studied in great detail and the role of Wnt signaling in this process is 
well described, the contribution of epidermal Wnt secretion in epithelial cell homeostasis remains 
poorly understood. To analyze the role of Wnt proteins in this process, we created a conditional 
knockout allele of the Wnt cargo receptor Evi/Gpr177/Wntless and studied mice that lacked  
Evi expression in the epidermis. We found that K14-Cre, Evi-LOF mice lost their hair during the 
first hair cycle, showing a reddish skin with impaired skin barrier function. Expression profiling 
of mutant and wild-type skin revealed up-regulation of inflammation-associated genes. Fur-
thermore, we found that Evi expression in psoriatic skin biopsies is down-regulated, suggesting 
that Evi-deficient mice developed skin lesions that resemble human psoriasis. Immune cell 
infiltration was detected in Evi-LOF skin. Interestingly, an age-dependent depletion of dendritic 
epidermal T cells (DETCs) and an infiltration of low T cells in Evi mutant epidermis was ob-
served. Collectively, the described inflammatory skin phenotype in Evi-deficient mice revealed 
an essential role of Wnt secretion in maintaining normal skin homeostasis by enabling a bal-
anced epidermal-dermal cross talk, which affects immune cell recruitment and DETC survival.
© 2013 Augustin et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the 
publication date (see http://www.rupress.org/terms). After six months it is available 
under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Un-
ported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
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recombination deleting exon 3 (Fig. 1, A–C). Global deletion 
of Evi expression using a pan­deleter (Evifl/fl, Cre­deleter) led 
to mid­gestational embryonic lethality phenocopying Wnt3a­
deficient mice, as also reported previously (Fig. 1 D; Fu et al., 
2009). Conditional epidermal deletion of Evi was next per­
formed by crossing Evifl/fl mice with K14­Cre mice, which 
spatially directs Evi deletion into squamous epithelial cells. 
Expression of the K14 promoter starts during embryonic de­
velopment (embryonic day 12 [E12]) and remains high in 
haired as well as hairless skin (Huelsken and Birchmeier, 2001; 
Huelsken et al., 2001). K14­Cre is expressed in epithelial basal 
cells, as well as appendages of the skin, and has restricted expres­
sion in other epithelial structures like the thymus, esophagus, 
and forestomach. Evifl/+, K14­Cre+ mice appeared pheno­
typically normal. Evifl/fl, K14­Cre+ (Evi­LOF) mice were born 
at Mendelian frequency and after birth were indistinguishable 
from their wild­type littermates. As of postnatal day 6, Evi­
LOF pups showed a “red nose” phenotype and retained visibly 
less dense fur (Fig. 1 E). In addition, Evi­LOF animals showed 
a growth retardation phenotype and remained significantly 
smaller until they died within 10 wk (unpublished data).
Evi­LOF mice started losing their hair during the first hair 
cycle (Fig. 1 F). Also, ears appeared increasingly malformed 
(Fig. 1 G), suggesting that epidermal Wnt secretion also affects 
underlying cartilage formation. In addition, the skin became 
irritated, flaky, and thin with exposed blood vessels (Fig. 1 H), 
and the eyes of Evi­LOF appeared swollen (Fig. 1 I). Based on 
these visible skin alterations, we performed an extensive histo­
logical comparison of wild­type and mutant skin. First, we 
validated the deletion of epidermal Evi expression by immuno­
histochemistry (Fig. 1 J). Control skin keratinocytes promi­
nently expressed Evi in an irregular pattern. Similarly smooth 
muscle cells of underlying blood vessels were stained positively; 
whereas Evi protein was weakly detectable in dermal fibro­
blast, Evi protein was not detectable in Evi­LOF epidermis, 
confirming its successful depletion.
Hematoxylin & eosin (H&E)–stained sections of Evi­LOF 
skin revealed dramatic changes in skin structures, which be­
came increasingly severe during the first hair cycle of the skin. 
Fewer hair follicles developed in Evi­LOF skin, which de­
generated to cyst­like structures (Fig. 2 A). Pronounced scale 
formation was visible on the skin of young pups and persisted 
throughout the lifetime, indicating impaired keratinocyte 
differentiation. The epidermis of mutant skin appeared hy­
perproliferative in contrast to a thin dermis and hypodermis 
(Fig. 2 A). In normal skin, proliferating cells were detectable 
in the basal layer of the epidermis and in hair follicle bulbs. 
The distribution of phospho­H3–positive cells in the skin of 
Evi­LOF mice showed an increased proportion of proliferat­
ing basal cells in Evi­LOF, whereas the number of proliferat­
ing cells in the bulb was decreased (Fig. 2, B and C). This data 
indicates that Evi­LOF epidermis was renewed by rapidly di­
viding cells in the basal layer and not by proliferating bulge 
stem cells. Collectively, Evi­LOF skin was displayed by im­
paired hair follicle formation, dermal degeneration, and en­
hanced keratinocyte proliferation.
and components of the Wnt signaling pathway was reported 
for the Goltz­Gorlin syndrome (Grzeschik et al., 2007). The 
Goltz­Gorlin Syndrome is an X­linked dominant disorder 
caused by mutations in the PORCN gene, which encodes for 
the acyl­transferase Porcupine, a component of the Wnt signaling 
pathway. Porcupine is required for the palmitoylation of Wnt 
proteins in the ER, a necessary step in Wnt secretion. PORCN 
mutations cause hypoplastic, hyperpigmented skin as well as 
digital, ocular, and dental malformations (Lombardi et al., 2011; 
Liu et al., 2012). Similarly, two recent studies reported an up­
regulation of Wnt5A and differential expression of other Wnt 
pathway components in human psoriatic plaques (Gudjonsson 
et al., 2007; Reischl et al., 2007; Romanowska et al., 2009).
Wnt proteins are lipid modified in the Wnt­producing cell 
and require the cargo receptor Evi/Wls for exocytosis (Bänziger 
et al., 2006; Bartscherer et al., 2006; Goodman et al., 2006). 
They trigger distinct intracellular cascades divided mainly in 
­catenin–dependent/canonical and ­catenin–independent/ 
noncanonical signaling (Clevers and Nusse, 2012). Canonical 
Wnt signals play fundamental roles during hair follicle de­
velopment (Huelsken and Birchmeier, 2001; Alonso and 
Fuchs, 2003). Beyond controlling the initiation of epider­
mal appendage formation, Wnt signaling contributes to the 
spatial hair follicle distribution and orientation (Schlake and 
Sick, 2007).
The present study aimed at analyzing the role of Evi­ 
regulated Wnt secretion in the epidermis. To this end, we con­
ditionally deleted the Evi gene in squamous epithelial cells in 
mice. An abrogation of Evi function resulted in inflamed skin 
with hyperplasia, impaired barrier function, and differentia­
tion of epidermal keratinocytes as well as vascular hyperplasia. 
We observed significant dermal infiltration of innate immune 
cells and T cell recruitment. Interestingly, a significant reduc­
tion in dendritic epidermal T cells (DETCs) with high levels 
of  T cell receptor was identified in Evi mutant skin. The 
depletion of DETC started postnatally, suggesting that Wnt­
secreting keratinocytes play important roles in DETC sur­
vival in the murine skin. Moreover, a second low T cell 
population invaded Evi­LOF epidermis, suggesting that mo­
dulation of  T cell populations contributed to the observed 
immune cell dysregulation. In addition, Evi­deficient keratin­
ocytes showed increased activation of STAT3. Collectively, 
the deletion of Evi in keratinocytes created a skin profile re­
sembling chronic cutaneous inflammatory diseases. The data 
indicates that aberrant control of Wnt secretion leads to se­
vere aberrations during skin homeostasis. We observed that 
reduced expression of Evi in human psoriatic skin biopsies 
strengthens the relevance of  Wnt signaling in human psoria­
sis. Therefore, Evi­deficient mice may represent a novel model 
to study psoriasiform dermatitis–related diseases.
RESULTS
Epidermal deletion of Evi leads to growth retardation,  
early lethality, and irritated skin
To investigate the role of Wnt secretion during organ devel­
opment, we generated Evifloxed/floxed mice by homologous 
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the outer layer of keratinocytes in Evi­LOF mice but not as 
consistently as in control mice (Fig. 3 A). K5­, K8­, and K14­, 
as well as basal layer– and hair follicle–expressed marker were 
similarly distributed in the follicles of wild­type and Evi­LOF 
To determine whether other changes in epithelial structures 
were present in Evi­LOF animals, we probed for the expres­
sion of epidermal differentiation markers such as loricrin, 
Keratin­5 (K5), K8, K14, and K16. Loricrin was expressed in 
Figure 1. Generation of floxed Evi mice and conditional depletion in squamous epithelium. (A) Targeting strategy for the conditional Evi allele 
with loxP sites flanking exon3. Thin lines, mouse genomic DNA; gray boxes, sequences included in the targeting construct; triangles, LoxP/FRT sites; black 
boxes, probes for Southern blot analysis; arrows, PCR primer. (B) Southern blot analysis of genomic ESC DNA digested with BamHI and Bmt1 confirmed 
homologous recombination with a 5-primed and 3-primed probe. (C) PCR analysis of genomic DNA amplified a 340-bp recombined/floxed and a 210-bp 
wild-type fragment. (D) Crossing of Evifl/fl with general Cre deleter generated embryonic lethal Evi knockout mice with defects in gastrulation (embryonic 
day 8.5 [E8.5]). (E) Evi-LOF and wild-type littermate at age P7 showing the red nose phenotype. (F) Skin phenotyping of Evifl/fl, K14-Cre mice (P50 mutant 
mice [right] and normal littermate [left]). (G) Ears. (H) Legs, exposed blood vessels are marked with arrows. (I) Eye. (J) Immunohistochemistry against Evi in 
the skin. A representative of three independent experiments is shown. Bars, 200 µm.
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Similar results were obtained with CD31­labeled skin sec­
tions (unpublished data), indicating that depletion of Wnt 
secretion in the epidermis triggered an angiogenic response 
in Evi­LOF skin.
Ultrastructural analyses revealed multilayering of the epider­
mis in Evi­LOF skin compared with single­layered wild­type 
epidermis. In addition, spongiosis was observed in Evi­LOF 
as a sign of ongoing inflammation and impaired fluid homeo­
stasis, whereas the dermis was thin but otherwise without path­
ological findings (Fig. 3 F).
The main important function of the skin is to build an 
effective barrier preventing biological, chemical, and physical 
mice, whereas they were expressed in several layers of the 
hyperproliferative epidermis in Evi­LOF mice (Fig. 3 A). In­
terestingly, K16 was enriched in Evi­LOF suprabasal keratin­
ocytes compared with wild­type controls (Fig. 3, A and B). 
K16 is a marker for differentiated keratinocytes, which is 
strongly induced during wound healing (Leigh et al., 1995). 
Besides providing mechanical integrity, networks of keratin 
filaments are also involved in cellular functions like apoptosis 
and stress response (Chamcheu et al., 2011). Therefore, we 
asked whether additional structural components were dif­
ferentially regulated and performed expression analysis by 
RNA­seq of epidermal sheets. We found that a total of 1,298 
transcripts were differentially expressed in Evi­LOF epider­
mis of P21 mice compared with control littermates. Analyses 
of differing genes revealed the following changes in a set of 
keratins: K1, K6a, K7, K16, K17, K24, K42, and K79 were 
found to be up­regulated, whereas the expression of K2, K15, 
K32, and K77 was down­regulated (Fig. 3 B). Both, K6 and 
K16 are involved in wound regeneration, providing strength 
and resiliency to the skin (Leigh et al., 1995). K1 is involved 
in hyperkeratosis and contributes to stratum corneum thicken­
ing. K17 promotes keratinocyte proliferation and tumor growth 
by enforcing the immune response in the skin (Depianto et al., 
2010). Mutation in the spinous layer keratin K2 has been asso­
ciated with bullous congenital ichthyosiform erythroderma 
(Akiyama et al., 2005). K15 expression is down­regulated in 
hyperproliferative skin, contributing to psoriasis and hypertro­
phic scars (Waseem et al., 1999). K77 and K32 are involved 
in hair fiber formation. In summary, the analysis of keratin 
expression indicates that loss of epidermal Wnt secretion led 
to differentially regulated expression of several keratin proteins, 
which are involved in skin regeneration and inflammation.
Moreover, inflammation­associated cytokine expression 
pattern is altered in Evi­LOF skin, indicating ongoing in­
flammatory cascades (Fig. 3 C). Most prominently, the chemo­
kines Cxcl1, Ccl2, Ccl6, Ccl20, and Ccl22 were up­regulated, 
Cxcl14 and Cc127a were down­regulated, and expression 
of the some IL1 family members and IL17f were increased, 
whereas IL15, IL6f, and IL34 were decreased. Several IL1 
family members are involved in cutaneous inflammation. The 
related IL1 ligands IL1f5, IL1f6, IL1f8, and IL1f9, which were 
up­regulated in Evi­LOF skin, are linked to cutaneous altera­
tions similar to psoriasis (Blumberg et al., 2007; Onoufriadis 
et al., 2011). The cytokines IL1f6, IL1f8, and IL1f9 activate 
pathways leading to NF­B and MAPK signaling, suggesting 
a cross talk of these pathways and Wnt signaling in the skin. 
In summary, this cytokine signature contained genes involved 
in lymphocyte recruitment (Cxc family members, Ccl family 
members, and IL17), activation (IL1), proliferation, and survival 
(IL6, IL7, and IL15) and shows that epidermal loss of Evi cor­
related with activated immune and inflammatory response.
Inflammation has emerged as a driver of angiogenesis. For 
this reason, we analyzed the vessel density in the dermis of 
Evi­LOF skin and wild­type littermates. Quantification of 
H&E­stained sections of Evi­LOF revealed significantly more 
blood filled vessels compared with controls (Fig. 3, D and E). 
Figure 2. Hyperproliferation of basal cells in Evi-LOF epidermis. 
(A) H&E-stained sections of Evi-LOF and control skin at different ages. SG, 
sebaceous gland; Bu, bulge; DP, dermal papilla. Bars, 200 µm. (B) Phospho-
H3 stainings of skin sections of Evi-LOF and wild-type mice. Bars, 200 µm. 
(C) Quantitation of phospho-H3+–labeled basal cells/mm. Error bars repre-
sent SD. *, P < 0.05; **, P < 0.001, n = 3–4 per age and group. Results are 
combined from two independent experiments.
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mature epidermis. However, progressive depletion of Evi func­
tion in the epidermis of the pups altered skin penetration. 
Furthermore, the onset of the barrier alterations was in paral­
lel to first signs of inflammation (red nose phenotype, Fig. 1 E). 
The data indicates that barrier disruption is time­linked to 
the onset of skin inflammation and starts rather early in the 
disease development of Evi­LOF mice. Measurements of sur­
face body temperature of age­matched mice revealed reduced 
temperature of adult Evi­LOF mice, indicating impaired 
thermoregulation (Fig. 4 C). The mutant mice also showed a 
lack of fat tissue sustainment, which suggested that the mice 
might have balanced the lack of thermoregulation with a hy­
permetabolic response. Lack of fluid retention, thermoregu­
lation, and sustainment of fat tissue cause stress to the mutant 
invasion from the outside, as well as retaining solutes from 
the inside and maintaining thermoregulation (Proksch et al., 
2008). Proper epidermal stratification is crucial for the devel­
opment and homeostasis of epidermal barrier function. Impaired 
skin permeability function often correlates with inflamed tissue. 
Therefore, we performed dye­penetration assay with Luciferin 
yellow and transepidermal water loss (TEWL) analysis to ana­
lyze barrier function (Fig. 4, A and B). Both assays revealed a 
significant alteration in skin barrier function. Neonatal mice 
showed no skin barrier alterations, whereas older pups (>post­
natal day 6 [P6]) developed barrier defects, which lead to dye 
penetration (Fig. 4 A). Similarly, TEWL analysis revealed 
dramatic water loss in adult Evi­LOF mice (Fig. 4 B). There­
fore, we concluded that the mutant mice embryos formed 
Figure 3. Impaired keratin expression in Evi-LOF indicates ongoing inflammation. (A) Immunohistochemistry against -catenin and keratino-
cyte differentiation marker (loricrin, K5, K8, K16, and K14). Bar, 200 µm. (B) Expression pattern of differentially expressed keratins in Evi-LOF epidermis 
based on deep sequencing data. Values represent normalized log2 fold changes (n = 3, P < 0.05). (C) Heatmap showing cytokines differentially regu-
lated in Evi-LOF epidermis. Values represent normalized log2 fold changes (n = 3 per group, P < 0.05). (D) H&E-stained section of Evi-LOF and control 
skin. Vessels are marked with arrowheads. Bar, 200 µm. (E) Comparative analysis of dermal vessel density (n = 4 per group, error bars represent SD;  
*, P < 0.05). (F) Ultrastructural characterization of epon-embedded thin sections. D, dermis; E, epidermis (n = 3 per group). Results are combined from 
two (A–C and F) and three (D) independent experiments.
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et al., 2002). The dermis of K14­driven Evi­LOF mice was 
prominently infiltrated by neutrophils starting around age P16 
(Fig. 5, A and B). Munro’s microabscesses were distributed 
over the skin of Evi­LOF mice, which we never observed in 
control littermates (Fig. 5 A). To rule out that neutrophils were 
recruited to the skin as a result of bacterial infection, mice 
were orally treated with the broad­spectrum antibiotic cipro­
floxacin for 7 d and analyzed thereafter (Fig. 5 C). No differ­
ence in neutrophil infiltration between the littermates with or 
without antibiotic treatment was observed, indicating that 
the neutrophil recruitment was not an effect of a bacterial 
infection. Furthermore, overall pathophysiological analysis of 
mutant mice revealed no evidence for microbial infection.
Analysis of expression profiling data of mutant and wild­
type epidermis showed that the chemokine Cxcl1 (log2 fold, 
2.02; adjusted [adj.] p­value, 0.0006) and its receptor Cxcr2 
(log2 fold, 4.4; adj. p­value, 9 × 1036) were differentially reg­
ulated (Fig. 3 C). Both genes are involved in neutrophil mobi­
lization and likely contribute to the enhanced neutrophil 
invasion in Evi­LOF skin. We also examined the infiltration 
of other innate immune cells like macrophages (CD68) and 
mast cells (Toluidine) in Evi­LOF skin and controls. Macro­
phages as well as mast cells were more abundantly detected in 
mice and might result in growth retardation and early lethality. 
In addition expression analysis of epidermal sheets revealed 
pronounced changes in the transcription of EDC (epidermal 
differentiation complex) genes (de Guzman Strong et al., 2010; 
Fig. 4 E). Particularly, most LCE (10 out of 16 genes) and 
SRPP (12 out of 15 genes) family members are differentially 
regulated, supporting altered cornification and barrier func­
tion in Evi mutant mice. Moreover, LCE3 genes are also in­
volved in barrier repair and psoriatic lesions (Bergboer et al., 
2011). Collectively, our results show that the deletion of the 
Wnt secretory factor Evi in the epidermis led to a complex 
and severe phenotype including erythema, scaling, altered kera­
tinocyte differentiation, and neoangiogenesis, as well as signs 
of inflammation and skin barrier perturbations.
Loss of epidermal Wnt secretion leads to chronic 
inflammatory skin disease
The observed phenotypic characteristics shared similarities 
with inflamed skin. We therefore further investigated the skin 
and performed immunohistochemical analyses of the proin­
flammatory marker S100A9/Calgranulin B (Nacken et al., 
2003). Calgranulin B is highly expressed in neutrophils and is 
considered to be a potential mediator in psoriasis (Semprini 
Figure 4. Evi-LOF mice develop skin barrier defects. (A) Lucifer yellow penetration analyzed in newborns and adult mice (bar, 200 µm; n = 4 per 
group). (B) TEWL analysis of pups and adult mice. Error bars represent SD. (C) Skin surface temperature on shaved skin and body temperature (n = 5 per 
group; **, P < 0.001). (D) Log2 fold changes of EDC gene expression in the epidermis of Evi-LOF skin. Genes with adjusted p-values <0.05 were labeled in 
dark gray and genes with adjusted p-values >0.05 were labeled in light gray. Results are combined from three (A–C) and two (D) independent experiments.
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(Huelsken et al., 2001). Histological quantification of neutro­
phil recruitment and quantification of S100A9 mRNA expres­
sion revealed enhanced infiltration of neutrophils, although to a 
lesser extent than in Evi­LOF mice (Fig. 5, E and F). These data 
indicate that canonical Wnt signaling in keratinocytes contrib­
utes to skin homeostasis and inflammation. The phenotype of 
Evi­LOF mutant additionally revealed a reduction of dermal 
fibroblasts (Chen et al., 2012), which might lead to a more severe 
inflammatory phenotype compared with ­cat­LOF.
Next, we asked whether neutrophil recruitment was also 
affected in Evi gain­of­function animals, assuming that Evi­GOF 
Evi­LOF skin, indicating that a spectrum of innate immune 
cells was involved in the Evi­LOF pathogenesis (Fig. 5 D).
Evi controls the secretion of both canonical and non­
canonical Wnt ligands. Therefore, we asked whether Evi­LOF 
skin inflammation correlated with ­catenin or ­catenin–
independent Wnt signaling. ­cateninfl/fl × K14 mutant mice 
(­cat­LOF) mice were viable. Hair follicle formation was 
impaired in mutants, and ­cat­LOF mice lost their hair dur­
ing the first hair cycle, as previously described (Huelsken et al., 
2001), and showed a hyperproliferative epidermis; however, 
they have not been analyzed for an inflammatory phenotype 
Figure 5. Wnt signaling affects neutrophil recruitment in the skin. (A) Immunohistochemistry against S100A9 in Evi-LOF skin. (B) Quantitation of 
S100A9-labeled cells in the dermis of Evi-LOF and wild-type littermate skin in differently aged mice (n = 4 per age and group). (C) Quantitation of S100A9-
labeled cells after treatment of Evi-LOF mice and control littermates with or without ciprofloxacin (Cipro; n = 3 per group). (D) Stainings of mast cell (Tolu-
idine blue) and macrophage (CD68) infiltration (n = 4 per group). (E) Quantitation of S100A9-labeled cells in -catenin, K14-Cre LOF (P60) mice (n = 4 per 
group). (F) Normalized mRNA expression levels of S100A9 in Evi-LOF and -cat-LOF mice. Horizontal bars show mean values (n = 4 per group). (G) H&E-
stained sections of ROSA26:Evi-YFP (Evi-GOF) knockin and control mice. (H) Expression of Evi-YFP protein in the skin. (I) Immunohistochemistry against 
S100A9 in skin sections of Evi-GOF and control mice 24 h after TPA application (n = 5 per group and time point). (J) Time-dependent quantitative analysis 
of dermal S100A9 infiltration after TPA application in Evi-GOF skin compared with control littermates (n = 5 per group and time point). Results are com-
bined from three (A–C and E–I) and two (D) independent experiments. Error bars reflect SD (B–E) or SEM (J). *, P < 0.05; **, P < 0.001. Bars, 200 µm.
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should result in the opposite effect than Evi­LOF. We previ­
ously generated ROSA26:Evi­YFP (Evi­GOF) knockin mice 
(Augustin et al., 2012) and showed that overexpression of Evi­
YFP increased Wnt reporter activity in embryonic stem cell 
culture. These experiments suggested that the overexpressed 
Evi protein was functional and secreted Wnt proteins (Augustin 
et al., 2012). Evi­GOF mice were viable, fertile, and showed no 
major phenotypic alterations. Overall skin architecture of Evi­
GOF mice was comparable to control skin, indicating that 
ectopic Evi expression could be tolerated without major patho­
physiological consequences (Fig. 5 G). These findings sug­
gested that additional parameters were necessary to overactivate 
Wnt signaling in vivo. Specific immunofluorescence analysis 
of YFP revealed pronounced labeling of keratinocytes, confirm­
ing that Evi­YFP protein was ectopically expressed in the skin 
(Fig. 5 H). We consequently asked if Evi­GOF showed an ef­
fect in a 12­O­tetradecanoylphorbol­13­acetate (TPA) assay 
of acute regenerative inflammation. TPA induces strong up­
regulation of proinflammatory signaling molecules and leads to 
dermal infiltration by immune cells and epidermal hyperplasia. 
Neutrophils represent the first immune cells recruited after in­
flammatory induction. We analyzed the dermal infiltration of 
neutrophils in Evi­GOF and wild­type controls over time. Skin 
specimens were collected 6, 24, and 48 h after TPA application. 
Strong infiltration of neutrophils was observed after 6 and 24 h 
of treatment, whereas the infiltration disappeared after 48 h 
(Fig. 5, I and J). However, neutrophil infiltration was significantly 
less in Evi­GOF skin. Acetone­treated Evi­GOF and wild­type 
mice showed no enhanced immune cell infiltration. The ob­
served reduction of dermal neutrophil infiltration in Evi­GOF 
mice is consistent with the Evi­LOF phenotype, which was 
characterized by pronounced neutrophil recruitment. Both lines 
of experimental approaches support an important role of Evi 
in skin and immune cell cross talk and suggest a gatekeeper 
function of Evi in maintaining skin homeostasis.
Epidermal depletion of Evi leads to loss  
of  TCR+ T cells in the skin
Psoriatic skin lesions are usually infiltrated by cell of the innate, 
as well as adaptive, immune system (Sabat et al., 2007; Nestle 
et al., 2009). Stainings of neonatal skin with the pan–T cell 
marker CD3 showed typical labeling of DETC in Evi­LOF 
and control tissue, whereas additional dermal and epidermal 
T cell infiltration was absent (Fig. 6 A). DETCs constitute a 
 TCR+ T cell subpopulation, which abundantly expresses 
 T cell receptor and specifically localizes to the epidermis of 
the skin (Girardi, 2004). They reside in the epidermis during 
the life span of the mouse and are involved in host defense and 
wound repair (Asarnow et al., 1988).
 
Figure 6. Epidermal depletion of Evi led to loss of DETC and increase 
in CD3low low subpopulation in the skin. (A) Expression of CD3 on 
frozen skin sections of neonatal mice and paraffin skin section of P40 
mice. Bar, 200 µm. (B) FACS profile of CD3+ cells in skin and lymphatic 
tissue (n = 5 per group). (C) Quantification of immunohistochemically 
labeled DETC at different ages (n = 4 per group). (D) A representative FACS 
profile showing the frequency of CD3 and  TCR+ T cell subsets of neo-
natal and P60-old skin. (E) Age-dependent quantitation of CD3+, + cells 
in the epidermis of Evi-LOF and wild-type littermates. (F) Representative 
FACS profiles showing CD3+ and  TCR+ T cell subsets (P40) and further 
analysis regarding V3 TCR expression. Numbers in columns represent the 
number of analyzed animals. Results were pooled from three (A–C and F) 
and four (D–E) independent experiments. Error bars represent SD (B and C) 
or SEM (E). *, P < 0.05; **, P < 0.001; ***, P < 0.0001.
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CD3 staining of adult Evi­LOF skin revealed few labeled 
cells resembling DETC morphology and an additional smaller 
and less intensively stained population, indicating an infiltra­
tion of different subpopulations of CD3+ cells (Fig. 6 A). To 
analyze T cell distribution in adult Evi­LOF mice and wild­
type littermates, we compared the CD3+ population of the 
skin and lymphatic tissues (Fig. 6 B). This FACS­based analy­
sis confirmed that Evi­LOF epidermis and dermis had signifi­
cantly increased T cell infiltration, whereas the lymph nodes 
and spleen were unaffected. The results indicate ongoing T cell–
based inflammation in the skin of Evi­LOF mice. In addition, 
the CD3+ population of the mutant thymus was decreased, 
which suggests alterations in T cell development.
Interestingly, an age­dependent decrease of DETC was 
observed in Evi­LOF skin, whereas newborn mutant pups 
showed unchanged DETC populations (Fig. 6, C and D). Thus, 
it was unlikely that a failure in thymic DETC precursor gen­
eration was causally implicated in the absence of DETC in 
Evi­LOF skin. Instead, the data suggested that the survival of 
DETC was impaired in Evi­deficient epidermis.
Adult Evi­LOF epidermis contained a second  T cell pop­
ulation with diminished levels of CD3 and  T cell receptor 
levels (CD3low gdTCRlow) compared with DETC (CD3high, 
high; Fig. 6, D and E). FACS­based analyses revealed the 
absence of V3 TCR expression (Garman’s system) in the 
CD3 low, low population, indicating that these  T cells 
did not reflect features of DETC and probably represented 
infiltrated dermal or lymphoid  T cells (Fig. 6 F; Gray et al., 
2011; Mabuchi et al., 2011).
To rule out loss of DETC as a result of DETC emigration 
out of the epidermis, we prepared cell suspensions of the der­
mis, lymph nodes, and spleen and quantified DETC by FACS 
profiling (Fig. 7 A). DETC population is decreased in the 
dermis and not changed in lymphoid tissues, indicating that 
DETC did not migrate into adjacent tissue or lymphoid organs. 
The data supports our concept that survival of DETC is im­
paired in Wnt­deficient epidermis.
Next, we asked whether the DETC loss is a result of im­
paired proliferation and activation. Therefore, we labeled pro­
liferating cells with (29S)­29­Deoxy­29­fluoro­5­ethynyluridine 
(EdU) and quantified EdU­containing DETC by FACS. DETC 
isolated from epidermal, as well as dermal cell suspensions of 
mutant skin, revealed increased EdU incorporation, indicating 
enhanced cell proliferation (Fig. 7 B). In addition we analyzed 
the activation status of the DETC in Evi­LOF epidermal ear 
sheets and compared it to control mice (Fig. 7 C). As shown 
in Fig. 7 C, the majority of the DETC in control ears form 
dendritic spines (>2) typical for resting DETC, and only 5% 
are activated. However, Evi mutants obtained 65% acti­
vated DETC and <5% resting DETC, indicating that DETC 
Figure 7. Altered proliferation and activation of DETC in Evi-LOF 
mice. (A) FACS-based analysis of CD3highhigh cells in dermis, lymph 
nodes (LNs), and spleen. (B) EdU incorporation in epidermal and dermal 
CD3high cells. FACS plots on the right illustrate the gated populations.  
(C) Morphological analysis of the activation status of DETC in epidermal 
ear sheets. Activation status was determined based on number of spines. 
Bar, 200 µm. (D) CD3 staining of epidermal ear sheets of Evi, K14-Cre and 
-cat, K14-Cre in K14--cat-LOF mice. Bar, 400 µm (n = 4 per group). 
Numbers in columns represent the number of analyzed animals. Results 
were pooled from three (A and C) and two (B) independent experiments. 
Error bars represent SD. *, P < 0.05; **, P < 0.001.
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Figure 8. Thymic and thymocyte development in Evi-LOF mice and immunophenotyping of blood and lymphoid tissue. (A) Thymus weight 
normalized to body weight in mice of different ages (P4, P21, and P65). (B) H&E-stained sections of Evi-LOF and control thymi at different ages. Dashed 
lines indicate transition between cortex and medulla. Bar, 500 µm. (C) Total thymus cellularity in mice of different age. (D) Frequencies of CD4CD8 
double-negative (DN), CD4+ single-positive (CD4SP), CD8+ single-positive (CD8SP), and CD4+CD8+ double-positive (DP) thymocytes of P4 and P40 mice 
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in Evi­LOF skin had sensitized epidermal stress, got activated, 
and started to proliferate. These results reflect the typical 
phenotype of stimulated DETC. Loss of DETC is therefore 
not a result of absence of DETC activation and proliferation 
but rather results from lack of sustainment signals. Similarly, 
­catenin–K14­LOF mice showed reduced DETC popula­
tion, supporting a role of Wnt signaling in DETC mainte­
nance (Fig. 7 D).
Next, we asked whether  T cell ligands are changed in 
Evi­LOF skin. Skint1 is expressed in epithelial cells of the thy­
mus and the skin. It is involved in the selection of the DETC 
compartment in the thymus (Boyden et al., 2008; Barbee et al., 
2011). However, its function in the skin is still unclear. Skint1 
was up­regulated in Evi­LOF epidermis (log2 fold, 1.02; adj. 
p­value, 0.0001), suggesting that Skint1 expressed by keratin­
ocytes might contribute to the  T cell distribution in mu­
tant epidermis. Moreover, previous reports had shown that 
IL15 promotes  TCR+ T cell sustainment (Edelbaum et al., 
1995). Correspondingly, a significant reduction of IL15 ex­
pression was observed in Evi­LOF skin compared with wild­
type control (log2 fold, 1.85 reduction; adj. p­value, 2.2 × 
105). This data indicates that Wnt signaling is involved in 
IL15 expression in the skin, which plays an essential role for 
DETC survival.
The K14 promoter is also expressed by thymic epithelial 
cells (TECs) of the inner medullar region (McLelland et al., 
2011). We consequently asked if the restricted Evi depletion in 
TEC had an effect on the structure and T cell composition of 
the thymus. The relative weight of the thymus in Evi­LOF 
pups (P4) was similar compared with control mice. However, 
the weight of the thymus was significantly reduced in older 
mutant animals (P21 and P65), indicating that the thymi re­
gressed due to enhanced atrophy (Fig. 8 A). H&E stainings 
of P4 and P28 thymic sections revealed no differences in the 
overall thymic architecture between Evi­LOF and wild­type 
mice (Fig. 8 B). Cortex and medulla structures were clearly 
separated with comparable sizes in younger mice. Thymi of older 
mice (P90) had discernible differences in thymic architecture 
leading to a reduction of medulla in mutant mice (Fig. 8 B). 
Total thymus cellularity of P4 Evi­LOF thymi was unaltered 
(Fig. 8 C). However, thymus cellularity in atrophic thymi of 
older mice (P40) was 50% reduced (Fig. 8 C). Analyses of cell 
surface markers demonstrated that the thymocyte set distri­
bution (CD4CD8 double­negative [DN], CD4+ single­
positive, CD8+ single­positive, and CD4+CD8+ double­positive 
[DP] cells) of P4 Evi­LOF thymi were indistinguishable from 
control littermates (Fig. 8 D). Thymocyte populations of P40 
Evi­LOF thymi were significantly altered, with an increase in 
DN and loss of DP thymocytes, and reflect similar thymocyte 
distribution to that in endotoxin­induced thymic atrophy (Fig. 8, 
D and E; Billard et al., 2011).
In addition, altered distribution of leukocyte populations in 
the blood as well as increased population of activated CD4 cells 
in the lymph node of the mutants suggested disturbed homeo­
stasis and activation of cell­mediated immunity (Fig. 8, E and F). 
Reduced B cell compartment and increased granulocyte com­
partment in the bone marrow had been reported after inflam­
mation. Our data suggests that the blood phenotype mirrors the 
reciprocal production of B cells and granulocytes in the bone 
marrow under inflammation (Cain et al., 2009). Altered ratios 
of thymic  T cells versus  T cells, as well as between CD4 
and CD8 T cells, revealed significantly reduced ratios in adult 
mice, suggesting shifts in T cell maturation (Fig. 8 G). The data 
demonstrates that the thymic alteration in adult Evi­LOF mice 
also had an immune modulatory effect in the periphery. Collec­
tively, Evi­LOF mice develop atrophy of lymphoid tissues and 
impaired immune homeostasis, suggesting dysfunctions of cell­
mediated immunity and ongoing inflammation.
Further analyses of Evifl/fl × FoxN1­Cre (FoxN1­Evi­LOF) 
offspring were performed to clarify the initial cause of skin 
inflammation. FoxN1­Cre mice are commonly used as a Cre 
driver for thymic epithelium. The Cre expression is directed 
to TEC precursors as well as to mature TEC. Moreover, the 
FoxN1 promoter is active in some epithelial cells of the skin 
(Mecklenburg et al., 2001; Schlake, 2001; Gordon et al., 2007). 
FoxN1­Evi­LOF mice were viable and had slightly less dense 
hair than wild­type controls but showed no prominent signs of 
inflammation. DETCs were normally distributed and T cell in­
filtration was absent in mutant mice (Fig. 8 H). Consequently, 
Evifl/fl, FoxN1­Cre mice did not develop inflamed skin, which 
supports the concept that epidermal Evi depletion, but not aber­
rant T cell development, triggered the inflammatory cascades.
Collectively, the data indicate that depletion of epidermal 
Wnt secretion leads to an inflammatory phenotype, which 
enforced T cell recruitment but inhibited survival of DETC. 
This phenotype did not correlate with severe thymic or thy­
mocyte developmental defects. Rather, the dramatic reduc­
tion in thymic T cell development and loss of DP thymocytes 
in older Evi­LOF mice (P40) reflected characteristic changes 
after thymic atrophy in response to stress (Billard et al., 2011). 
Similarly, depletion of DKK1 in TEC had no effect on fre­
quency of thymocyte subsets (Osada et al., 2010).
derived from either females or males. Representative FACS plots were shown on the right. (E) Whole blood from adults mice was analyzed by FACS with 
the indicated antigens for T cells (CD3), B cells (CD45R), monocytes (CD11b+, Gr1), and granulocytes (CD11b+, Gr1+). (F) FACS-based analysis of naive 
(CD62L expressing) CD4+ and CD8+ T cells in secondary lymphatic tissue. Evi-LOF tissue had less naive CD4+ cells in the lymph node, indicating activation 
of cell-mediated immunity probably based on chronic skin inflammation and stress. (G)  and  T cells as well as CD4+ and CD8+ populations of the 
indicated tissues were analyzed via FACS profiling. Diagrams illustrate ratios of the populations and indicate impaired T cell homeostasis. Results were 
pooled from three (A, C, and D) from two (B and E–G) independent experiments. *, P < 0.05; **, P < 0.001; ***, P < 0.0001. Error bars represent SEM (A–D) or SD 
(E–G). (H) Skin sections of FoxN1-Evi-LOF (P90), K14-Evi-LOF (P40), and K14-cat-LOF (P60) were stained with CD3. Only K14-Evi-LOF and -cat-LOF 
mice revealed enhanced T cell recruitment. FoxN1-Evi-LOF skin had well developed hair follicles and no hyperproliferative epidermis. Bar, 250 µm (n = 4 
per group). Representative pictures of two independent experiments were shown.
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Evi is down-regulated in human psoriatic skin
Next, we asked whether Evi itself was differentially regulated 
in human psoriasis. We analyzed the expression of Evi by im­
munohistochemical stainings of unaffected and affected areas 
of biopsy samples from psoriatic patients (n = 12; Fig. 9 A). 
Evi was abundantly expressed in healthy skin with higher levels 
in the basal layer. In contrast, Evi expression was prominently 
down­regulated in psoriatic lesions (Fig. 9 B), suggesting 
a causative involvement of Evi in the development of the 
disease. Correspondingly, reanalysis of psoriatic and normal 
human skin expression studies (Yano et al., 2008) revealed a 
significant reduction of Evi mRNA expression in psoriatic 
skin lesions (log2 fold change 0.8, adj. p­value 7.63 × 109). 
In addition, gene set enrichment analysis comparing psoriatic 
skin profile (Swindell et al., 2011) with Evi­LOF expression 
data showed a significant correlation with genes up­regulated 
in psoriasis (FWER p­value of down­regulated genes 0.057, 
not depicted; Fig. 9 C).
Evi-deficient keratinocytes induce inflammation  
via STAT3 activation
STAT3 signaling is involved in skin wound healing. Aberrant 
wound healing response has been shown for psoriatic epithe­
lium (McKenzie and Sabin, 2003). Consequently, consistent 
up­regulation of STAT3 signaling in keratinocytes contributes 
to skin diseases like psoriasis (Sano et al., 2005). IL17f reflects 
a proinflammatory cytokine up­regulated in Evi­LOF skin 
(Fig. 3 C) and is known to activate STAT3 signaling. A previous 
study also revealed that IL17a, which is highly homologous 
to IL17f, activates via STAT3 the expression of the psoriasis­
associated K17 (Swindell et al., 2011). To analyze whether 
STAT3 signaling is induced in Evi­LOF skin, we examined 
the levels of phosphorylated STAT3. Evi­LOF epidermal sec­
tions showed a prominent nuclear staining of activated STAT3 
compared with control tissues (Fig. 10 A).[ID]FIG10[/ID] Correspondingly, 
protein levels of phosphorylated STAT3 were significantly in­
creased (Fig. 10 B). Analysis of RNA­seq expression data of epi­
dermal sheets revealed several STAT3 signaling–related genes, 
which were differentially expressed in Evi­LOF skin. Several 
cytokines (Ccl22, Ccl20, Cxcl1, Ccl2, IL1f5, and IL15) in­
volved in immune cell mobilization were significantly changed 
in Evi­LOF epidermis (Fig. 10 C). Histochemical stainings of 
K14–­catenin mice revealed enhanced nuclear STAT3 in 
K14–­catenin–LOF skin, indicating that canonical Wnt sig­
naling contributes to activation of STAT3 (Fig. 10 D). The 
data suggest that Wnt secretion functions upstream of STAT3 
in an autocrine manner.
DISCUSSION
Ablation of -catenin causes a lack of placode formation during 
embryogenesis and loss of hair in the first hair cycle, suggesting 
that ­catenin–dependent Wnt signaling controls differentia­
tion of stem cells into follicular or epidermal lineages (Huelsken 
et al., 2001; Akiyama et al., 2005). Recent studies showed that 
ectodermal Wnt secretion is required for hair follicle initiation 
and proliferation of dermal fibroblast (Chen et al., 2012; Myung 
et al., 2013). Ectopic expression of the secreted canonical Wnt 
signal inhibitor DKK1 in epidermal cells displayed develop­
mental skin defects (Andl et al., 2002). K14­driven loss of Apc 
resulted in delayed and aberrant hair follicles morphogenesis 
as well as thymus degeneration (Kuraguchi et al., 2006). How­
ever, no Wnt­related mouse model has so far addressed the 
effect of Wnt signaling in skin homeostasis with respect to in­
flammation. In the present study, the Evi gene was condition­
ally depleted in squamous epithelial cells. Abrogation of Evi 
function in these mice resulted in inflamed skin with hyperpla­
sia, impaired differentiation of epidermal keratinocytes and bar­
rier function, vascular hyperplasia, and infiltration of immune 
cells. Significant infiltration of leukocytes like neutrophils was 
observed. Neutrophils are effector cells of the innate immune 
response and play important roles during tissue damage in 
acute disease as well as chronic diseases. In psoriasis, promi­
nent infiltration and microabscess formation by neutrophils 
is a characteristic feature (Schön et al., 2000). Expression of che­
moattractants together with the corresponding receptors by 
neutrophils is required to recruit neutrophils to the site of in­
flammation (Sadik et al., 2011). The chemokine Cxcl1 and its 
receptor CxcR1 play important roles in neutrophil mobiliza­
tion. Both genes were significantly up­regulated in Evi­LOF 
skin. In addition, Cxcl1 is a target gene of STAT3, which was 
Figure 9. Evi was down-regulated in human psoriasis. (A) A repre-
sentative analysis out of 12 psoriasis samples and control tissue stained 
against Evi. Bar, 100 µm. (B) Quantitation of Evi expression in skin biop-
sies based on immunohistochemistry (Error bars represent SD, n = 12;  
**, P < 0.001). Results were pooled from two independent experiments.  
(C) Enrichment plot showing a significant correlation between the 50 
most up-regulated genes in human psoriasis compared with the expres-
sion profile of Evi-LOF epidermal sheets.
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also activated in Evi­LOF skin. These data support our pre­
vious findings of Evi function during glioma tumorigenesis 
(Augustin et al., 2012), which had indicated that STAT3 sig­
naling functions downstream of Evi. Moreover, STAT3 has 
previously been shown to play a major role in skin wound 
healing and is also up­regulated in human psoriatic lesions. As 
such K5­STAT3 transgenic mice develop psoriasis­like pheno­
type (Sano et al., 2005).
The existence of impaired skin permeability function is 
widely accepted in inflammatory skin diseases like atopic der­
matitis and psoriasis (Proksch et al., 2008). Whether the barrier 
disruption is followed by inflammation or whether inflamma­
tion leads to permeability alterations is not clear. A definite con­
clusion about the initial contribution of altered skin barrier 
function or inflammation in our mouse model is also difficult 
because the defect appears to arise together with first signs of 
skin inflammation. However, skin barrier alteration in Evi­LOF 
mice precedes the onset of the adaptive immune system activa­
tion because infiltration of T cells is significantly observed in 
juvenile mice and not pups. Cutaneous barrier defects have not 
been linked to the altered Wnt signaling pathway before. There­
fore, we believe that this Wnt­associated phenotype is an inter­
esting finding and will open new questions for future studies.
The model described in this study establishes that epider­
mal alterations in Wnt secretion induce cutaneous inflammation. 
Current concepts of inflammatory skin disorders postulate an 
important functional role of T cells in the pathogenesis of 
the disease (Lowes et al., 2007). Consistent with these reports, 
T cell recruitment was observed in Evi­LOF skin. Unlike the 
vast majority of mature  T lymphocytes, which reside in 
secondary lymphoid organs and are recruited upon immune 
response, subsets of  T cells preferentially reside in epithe­
lia such as the epidermis, gut, lung, or the genitourinary tract. 
FACS profiling of mutant adult epithelium revealed two  
TCR+ populations, a CD3highhigh and a second subpopula­
tion with CD3lowlow cells. Previous studies based on human 
psoriatic patient material had indicated that the  T cell pop­
ulation is enhanced in psoriatic plaques (Seung et al., 2007). 
Similarly, the appearance of CD3lowlow cells in IL23­induced 
psoriatic dermatitis suggests a common mechanism between 
this psoriasis mouse model and Evi­LOF skin (Mabuchi et al., 
2011). Functional impairment at an epithelial interface can be 
attributed to up­regulation of local  TCR subsets. Never­
theless, the observed depletion of DETC (CD3highhigh), 
which started postnatally, suggests that Wnt­secreting keratin­
ocytes are essential for DETC survival in the murine skin. 
DETCs play a major role in the maintenance of the epidermal 
barrier and confine inflammatory infiltration of tissue pro­
voked by conventional  T cells (Hayday and Tigelaar, 2003; 
Bonneville et al., 2010; Macleod and Havran, 2011). It has been 
shown that DETC­deficient NOD mice develop spontane­
ous dermatitis (Girardi, 2004), suggesting that the absence of 
Figure 10. STAT3 signaling is activated in Evi-
LOF skin. (A) Immunohistochemistry against P-STAT3. 
Bar, 200 µm (n = 4 per group). (B) Quantitative West-
ern blot analysis of P-STAT3 expression in the epider-
mis. (n = 8 per group; Error bars represent SD; *, P < 
0.05). (C) Heatmap showing STAT3 signaling–related 
genes, which are differentially regulated in the epider-
mis of Evi-LOF and control mice. Values represent 
normalized log2 fold changes (n = 3 per group, P < 
0.01). (D) Immunohistochemistry against P-STAT3 in 
-catenin-LOF epidermis. Bar, 200 µm (n = 4 per 
group). Results were pooled form three (A and B) and 
two (C and D) experiments.
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DETC in Evi­deficient mice contributed to the observed im­
mune cell dysregulation. IL15 is preferentially expressed in non­
lymphoid tissues and promotes growth of DETC (Edelbaum 
et al., 1995). Moreover, IL15­LOF mice were deficient in 
epidermal DETC cells, indicating that IL15 is essential for 
the survival of DETC in the skin (De Creus et al., 2002). 
The down­regulation of IL15 in Evi­LOF skin suggests a role 
of IL15 as limiting survival factor of DETC in Evi mutants. 
Interestingly, other  T cell subpopulations, except DETC, 
are independent of IL15 (Sumaria et al., 2011).
The results of this study also reveal that partial Evi defi­
ciency in TECs did not contribute to aberrant T cell devel­
opment. Furthermore, the phenotypic analysis of skin samples 
from Evifl/fl FoxN1­Cre (FoxN1­Evi­LOF) mice was con­
sistent with these results. FoxN1 expression is restricted to 
epithelial cells of the thymus from earliest stage of thymus 
organogenesis and subsets of keratinocytes in the epidermis 
and in hair follicles (Mecklenburg et al., 2001; Schlake, 2001; 
Gordon et al., 2007). FoxN1­Evi­LOF mice lead to a mosaic 
depletion of Evi in the epidermis, which caused minor hair 
loss in the mutant skin. In contrast, FoxN1­Cre induced a more 
penetrant excision of the Evi gene in thymus epithelium com­
pared with K14­Cre and, therefore, a more efficient thymic 
epithelial knockout. Nevertheless FoxN1­Evi­LOF mice did 
not develop skin inflammation comparable to that of K14­
Evi­LOF, supporting a model whereby Evi depletion in kera­
tinocytes is responsible for the initiation of the psoriasiform 
dermatitis–like phenotype.
Much progress has been made in the past in defining 
molecular lesions, which are associated with predisposition to 
chronic inflammatory skin diseases and consequently also in 
the development of novel therapeutic modalities. Consider­
ing the heterogeneity of the patient phenotypes, the aim of 
future treatment will be to reduce the immune response and 
associated angiogenesis as well as hyperplasia. This study shows 
that epidermal depletion of the Wnt secretion factor Evi un­
expectedly triggered skin barrier defect, immune infiltration, 
and the growth of cutaneous blood vessels and keratinocytes. 
Taking into account that chronic inflammatory skin diseases 
are complex multifactorial disorders, which beyond patient­
specific heterogeneity also have many inflammatory genes in 
common, Evi­deficient mice reflect similarities to human cu­
taneous skin inflammation and suggest that our mutant mice 
may represent a novel model for psoriasiform dermatitis– 
related diseases. Future studies into the development of novel 
therapeutics should consider the contribution of Wnt signal­
ing on disease­associated immune modulation.
MATERIALS AND METHODS
Mice. The vector for the targeting of the Evi locus contained loxP sites 
flanking exon 3 of the Evi gene. The loxP sites enclosed a FRT­flanked pgk­
neo selection cassette, which was excised in vivo using a flippase­expressing 
mouse line. The targeting construct was introduced in C57BL/6 embry­
onic stem cells, which were injected into blastocysts to generate chimeric 
mice. Three independently targeted ES cell clones gave rise to mutant mice. 
Mice were genotyped by PCR and Southern blot analysis. The following 
primers were used to identify wild­type and recombinant alleles by PCR: 
forward, 5­AAGGAAACGAGATTGAGATGAGG­3; reverse, 5­GTT­
TATTTTTCCTCTTACCACTCTG­3. Generation of the mice was per­
formed by Taconic Artemis.
For Southern blot analysis, genomic DNA was digested with BamHI 
and Bmtl and probed with fragments, which were amplified with the follow­
ing primers: probe1, forward 5­TAGGAGAATATGAGTTGAAAAGAGG­3, 
reverse 5­AGGTGTGCCCTTTGAGAAAAGATC­3; and probe 2, for­
ward 5­AATTAGCCTGTCATCTAGATTGTG­3, and reverse 5­ACA­
TTAAAGGCACAGATCTACAAGG­3. ROSA26:Evi­YFP (Evi­GOF) 
were previously described (Augustin et al., 2012). In brief, Evi cDNA was 
C­terminally tagged with YFP and inserted into the ROSA26 locus by ho­
mologous recombination. A loxP­flanked ­geo cassette was integrated pre­
ceding the Evi sequence.
Floxed Evi (Evifl/fl) mice were crossed to Cre­deleter mice (Schwenk 
et al., 1995) or keratinocyte­specific keratin14 promoter (K14­Cre) to delete 
exon 3 and obtain Evi­LOF mice. Floxed ROSA26 Evi­YFP mice were 
crossed with Cre deleter to induce Evi­YFP expression. Floxed ­catenin 
(­catfl/fl) mice (Huelsken et al., 2001) were crossed with K14­Cre. Evifl/fl 
were crossed with FoxN1­Cre (Soza­Ried et al., 2008). Evifl/fl, ROSA26:
Evi­YFP, Cre­driver mice were on a C57BL/6 background (>10 back­
crosses), and ­cateninfl/fl mice were on a mixed background. Mice were 
housed in individually ventilated cages under specific pathogen­free condi­
tions. Animals had free access to food and water and lived in a 12­h light­dark 
cycle and were used at indicated ages. In each experiment mutant and con­
trol littermates were used. At least three litters were tested. Pap tests were 
performed to identify bacteria species on the skin of the analyzed mouse 
colonies. Some mice had been tested positive for Staphylococcus xylosus, which 
is a nonpathogenic commensal on the skin of mice. In parallel, the effective­
ness of the antibiotic Ciprofloxacin had been positively tested against the 
Staphylococcus present in the mouse colony and we had no evidence for an in­
fection with resistant strains. Therefore, mice were orally treated with Cipro­
floxacin to exclude bacterial infection as a reason for inflammation.
TPA-induced hyperplasia. 7–8­wk­old female wild­type and Evi­GOF 
mice were used for TPA experiments. Mice were shaved 3 d before treat­
ment. TPA (100 µl, 10 nM) was dissolved in acetone and applied on the dor­
sal skin. Skin specimens were collected after 6, 24, and 48 h and processed for 
paraffin embedding. The experiment was performed with five mice per gen­
otype and treatment group. Animal welfare and experimental procedures were 
performed in accordance to German animal protection law and were approved 
by the Regierungspräsidium Karlsruhe, Germany (AZ 230/11).
Western blotting. Epidermal sheets were isolated as previously described 
(Jensen et al., 2010). Skin specimens were incubated in dispase II overnight. 
The epidermis was separated mechanically from the dermis. Epidermal or 
total skin preparations were dissolved in lysis buffer containing 8 M urea in 
PBS. Lysates were incubated on ice for 10 min and centrifuged at 12,000 g 
for 20 min. The supernatants were collected and protein concentrations were 
determined by BCA method. 30 µg of proteins were separated on 4–12% 
NuPage gradient gels and transferred to PVDF membranes. Membranes 
were blocked and incubated overnight at 4°C for 1 h at room temperature 
with the following antibodies: P­STAT3 (New England BioLabs) and STAT3 
(New England BioLabs). Blots were then incubated with corresponding 
horseradish peroxidase–conjugated secondary antibodies (Sigma­Aldrich). 
Blots were also probed with a mouse monoclonal antibody against ­actin 
(Sigma­Aldrich).
Immunohistochemistry of tissue sections and epidermal sheets. 
Immunohistochemical studies were performed on paraffin­embedded and 
fresh frozen section as previously described (Augustin et al., 2012). In brief, 
antigen retrieval of paraffin sections was performed by microwaving the 
sections for 10 min in 10 mM citrate buffer, pH 6.0, or Tris­EDTA, pH 9. 
Fresh frozen sections were fixed with 4% paraformaldehyde or methanol. 
The sections were incubated overnight at 4°C with the following primary 
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antibodies: Evi (C1, DKFZ), CD3 (Abcam),  T cells (BD), CD31 (BD), 
CD68 (Santa Cruz Biotechnology, Inc.), S100A9 (Santa Cruz Biotechnol­
ogy, Inc.), ­catenin (BD), loricrin (Abcam), K14 (Abcam), K16 (Acris), Phos­
pho­H3 (New England BioLabs), and P­STAT3 (Abcam). All stainings were 
performed with AB complex enhancement. Nuclei were counterstained 
using Hoechst dye or Hematoxylin. For staining of epidermal sheets, ears 
were briefly washed in 70% ethanol. The ventral and dorsal sides of each ear 
were separated with forceps and incubated with epidermis down on 3.8% 
ammonium thiocyanate for 15 min at 37°C. Epidermal sheets were peeled 
off, put on a slide, and immunostained after fixation with 4% paraformal­
dehyde. Negative control experiments included omission of the primary 
antibody. Tissue analyses were performed with biopsies derived from at 
least three samples per genotype from independent litters. Stained sections 
were visualized by bright field or immunofluorescence microscopy (Axiovert 
200M with Visitron software; Carl Zeiss) at indicated magnifications. Image 
processing was performed with Photoshop CS4 software (Adobe). Quantifi­
cation of labeled cells was done with the help of ImageJ (National Institutes 
of Health. Psoriatic and uninvolved skin samples from patients were obtained 
from the Department of Dermatology and Venereology, University of Co­
logne. All samples were analyzed in an anonymized manner as approved by 
the local institutional ethics boards (AZ 188–8).
Ultrastructural analysis. Tissue pieces of 1 × 1 mm were fixed in 4% para­
formaldehyde overnight and embedded in epon. Thin sections of three dif­
ferent specimens per genotype were analyzed with an electron microscope 
(EM 900; Carl Zeiss).
Skin permeability barrier assays. Lucifer yellow dye assays were per­
formed with neonatal, P6, and adult mice. The mice were euthanized, 
gently shaved, briefly washed with 70% ethanol, and immersed for 1 h at 
37°C in 1 mM Lucifer yellow dye (Sigma­Aldrich) dissolved in PBS. Back 
skin strips were collected and frozen. Tissues were sectioned (10 µm), post­
fixed for 0.5 h in 4% paraformaldehyde, and counterstained using Hoechst 
dye. Stained sections were visualized by immunofluorescence microscopy 
(Axiovert 200M with Visitron software) at 20× magnification. Detection 
of TEWL was performed on shaved back skin with a Tewameter TW300 
(Courage Khazaka Electronics).
Tissue preparation and cell isolation for flow cytometry. Thymi, 
spleens, and lymph nodes of mice of different age were surgically removed, 
cut into small pieces, and teased to a single­cell suspension through a 70­µm 
cell strainer. Remaining cells were flushed out by rinsing with ice­cold 
FACS buffer (5% fetal bovine serum in PBS). Lymphocytes were centrifuged 
at 300 g for 5 min and resuspended in 0.5–2 ml FACS buffer. Cells were 
counted using a hemocytometer.
Back skin was rinsed with 70% alcohol, washed with PBS, and floated 
with the dermal side facing down in Dispase II solution (5 mg/ml Dispase II 
sterile filtrate (Roche) in T cell medium (10 mM Hepes buffer, 1 mM sodium 
private, 10% FCS, and 55 µM ­mercaptoethanol in RPMI) at 37°C for 
3 h. The dermis was mechanically separated from the epidermis on the next 
day. Both were cut into small pieces. The epidermis was incubated in 0.25% 
trypsin/EDTA in DMEM (Invitrogen) for 15 min. Dermis was digested 
with 0.2 mg/ml Collagenase I, 0.25% trypsin/EDTA in DMEM for 1 h at 
37°C. Cells were isolated by shaking vigorously until the solution became 
opaque. The cell suspension was filtered through a 70­µm cell strainer and 
T cell medium was added. The cells were centrifuged at 350 g for 5 min and 
resuspended in FACS buffer.
Cell suspensions were added to FACS buffer containing diluted anti­
body, incubated for 30 min at 4°C, washed, and resuspended in FACS buf­
fer. For blood cell phenotyping, 2 µl of whole blood was stained in 100 µl of 
total volume and analyzed. Immunophenotype data were acquired on a 
FACS Canto II (BD) and analyzed with FlowJo software (Tree Star; DKFZ 
Flow Cytometry Core Facility, Heidelberg, Germany).
Cell surface stainings were performed with anti–mouse directly conjugated 
monoclonal antibodies: anti­CD3 APC­eFluor780 (eBioscience), anti­CD45 
APC (BD), anti–TCR­ chain FITC (BD), anti–­TCR PE (BD), anti­
CD45R PCB (Invitrogen), anti­CD11b PE (Invitrogen), anti­Gr1 (BD), 
anti­CD4 FITC (BioLegend), anti­CD8a PE­Cy5 (BD), anti­CD44 Alexa 
Fluor 647 (BioLegend), anti­CD25 PE (BioLegend), anti­CD62L FITC 
(eBioscience), and anti­V3 TCR FITC (BD).
EdU labeling in vivo. Mice were injected i.p. with EdU (20 µg/g 
mouse) on 5 consecutive days. Epidermal and dermal cell suspensions 
were prepared at day 6 after initial EdU administration. Cells were stained 
with CD3 antibody as described in previous section. EdU­labeled cells 
were visualized by Click­iT EdU Pacific Blue Flow Cytometry Assay kit 
(Life Technologies).
Real-time transcription (RT)-PCR analysis. Total RNA was extracted 
from epidermal sheets of mouse back skin using RNeasy extraction kit 
(QIAGEN) according to the manufacturer’s instructions. Reverse transcrip­
tion and quantitative PCR was performed with 25 ng cDNA and Light­
Cycler 480 Probes Master as described (Roche). Relative mRNA expression 
was calculated as a fold change versus control. Primers were as follows: 
S100A9: probe #31, forward 5­CACCCTGAGCAAGAAGGAAT­3, and 
reverse 5­TGTCATTTATGAGGGCTTCATTT­3.
Expression profiling of Evi silencing experiments. RNA was extracted 
from epidermal sheets of three wild­type and Evi­LOF mice. The poly(A)+ 
fraction was isolated from each of the six samples with the Dynabeads 
mRNA Purification kit (Invitrogen). For each sample, a library for sequenc­
ing with a SOLiD4 sequencer was prepared. In brief, random primers with 
a hexamer adapter sequence were annealed to the 3 end of the mRNA and 
the first DNA strand synthesized. After RNA digestion, the DNA was puri­
fied using Agencourt RNAClean XP Beads. Random primers were annealed 
to the DNA for second strand synthesis. Agencourt Ampure XP Bead selec­
tion was used to purify and size select the double­stranded DNA. The library 
was amplified and barcoded.
Deep sequencing on a SOLiD4 system generated 50­base­long nucleotide 
sequences, referred to as “reads.” These were mapped using the whole tran­
scriptome analysis pipeline (Bioscope). This algorithm incorporates exon­
boundary information to map reads to a genome. For this analysis, the Mus 
musculus genome (NCBIM37) and associated exon boundary information 
was obtained from Ensembl (release 67). Bioscope adopts a seed­and­extend 
approach to map reads, and here a 25­base seed region was used, allowing two 
mismatches in the seed region. To ensure high accuracy, reads that mapped 
to multiple locations were discarded and only those reads that aligned with 
a high quality score (>20) were considered. The number of reads mapping 
to gene loci was quantified using Python package HTSeq (v0.4.7). Ex­
pression profiling data has been deposited in ArrayExpress (accession no. 
E.MTAB­1613).
Statistical analysis. Unless otherwise indicated, data are expressed as mean ± 
SD. Statistical significance was calculated by a two­tailed Student’s t test with 
unequal variance. A p­value of <0.05 was considered statistically significant 
and marked by asterisks. Two asterisks represent p­values of <0.01. Differential 
expression in RNASeq data were estimated using Bioconductor package 
DESeq (v1.7), with n = 3. A p­value of <0.05 was considered significant.
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